Jiang Y - Search Results

1

Visualizing Cytokeratin-14 Levels in Basal-Like Breast Cancer via ImmunoSPECT Imaging.

Ji H, Yuan L, Jiang Y, Ye M, Liu Z, Xia X, Qin C, Jiang D, Gai Y, Lan X. Ji H, et al. Among authors: jiang d, jiang y. Mol Pharm. 2022 Oct 3;19(10):3542-3550. doi: 10.1021/acs.molpharmaceut.2c00004. Epub 2022 Mar 14. Mol Pharm. 2022. PMID: 35285645

2

Synthesis and Preclinical Evaluation of ¹⁸F-PEG₃-FPN for the Detection of Metastatic Pigmented Melanoma.

Xu X, Yuan L, Yin L, Jiang Y, Gai Y, Liu Q, Wang Y, Zhang Y, Lan X. Xu X, et al. Among authors: jiang y. Mol Pharm. 2017 Nov 6;14(11):3896-3905. doi: 10.1021/acs.molpharmaceut.7b00607. Epub 2017 Oct 27. Mol Pharm. 2017. PMID: 29037039

3

PET Imaging of VCAM-1 Expression and Monitoring Therapy Response in Tumor with a ⁶⁸Ga-Labeled Single Chain Variable Fragment.

Zhang X, Liu C, Hu F, Zhang Y, Wang J, Gao Y, Jiang Y, Zhang Y, Lan X. Zhang X, et al. Among authors: jiang y. Mol Pharm. 2018 Feb 5;15(2):609-618. doi: 10.1021/acs.molpharmaceut.7b00961. Epub 2018 Jan 24. Mol Pharm. 2018. PMID: 29308904

4

Targeted radiotherapy of pigmented melanoma with ¹³¹I-5-IPN.

Xu X, Yuan L, Gai Y, Liu Q, Yin L, Jiang Y, Wang Y, Zhang Y, Lan X. Xu X, et al. Among authors: jiang y. J Exp Clin Cancer Res. 2018 Dec 11;37(1):306. doi: 10.1186/s13046-018-0983-0. J Exp Clin Cancer Res. 2018. PMID: 30537980 Free PMC article.

5

Correction to: Targeted radiotherapy of pigmented melanoma with ¹³¹I-5-IPN.

Xu X, Yuan L, Gai Y, Liu Q, Yin L, Jiang Y, Wang Y, Zhang Y, Lan X. Xu X, et al. Among authors: jiang y. J Exp Clin Cancer Res. 2019 Mar 25;38(1):135. doi: 10.1186/s13046-019-1141-z. J Exp Clin Cancer Res. 2019. PMID: 30909937 Free PMC article.

6

Preclinical Evaluation of a Fluorine-18 (¹⁸F)-Labeled Phosphatidylinositol 3-Kinase Inhibitor for Breast Cancer Imaging.

Altine B, Gai Y, Han N, Jiang Y, Ji H, Fang H, Niyonkuru A, Bakari KH, Rajab Arnous MM, Liu Q, Zhang Y, Lan X. Altine B, et al. Among authors: jiang y. Mol Pharm. 2019 Nov 4;16(11):4563-4571. doi: 10.1021/acs.molpharmaceut.9b00690. Epub 2019 Oct 4. Mol Pharm. 2019. PMID: 31553879

7

¹¹C-Labeled Pictilisib (GDC-0941) as a Molecular Tracer Targeting Phosphatidylinositol 3-Kinase (PI3K) for Breast Cancer Imaging.

Han N, Jiang Y, Gai Y, Liu Q, Yuan L, Wang Y, Li M, Zhang Y, Lan X. Han N, et al. Among authors: jiang y. Contrast Media Mol Imaging. 2019 Nov 3;2019:1760184. doi: 10.1155/2019/1760184. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 31787861 Free PMC article.

8

Evaluation of an Integrin α_vβ₃ and Aminopeptidase N Dual-Receptor Targeting Tracer for Breast Cancer Imaging.

Gai Y, Jiang Y, Long Y, Sun L, Liu Q, Qin C, Zhang Y, Zeng D, Lan X. Gai Y, et al. Among authors: jiang y. Mol Pharm. 2020 Jan 6;17(1):349-358. doi: 10.1021/acs.molpharmaceut.9b01134. Epub 2019 Dec 26. Mol Pharm. 2020. PMID: 31829615 Free PMC article.

9

Application and Evaluation of [^99mTc]-Labeled Peptide Nucleic Acid Targeting MicroRNA-155 in Breast Cancer Imaging.

Jiang Y, Gai Y, Long Y, Liu Q, Liu C, Zhang Y, Lan X. Jiang Y, et al. Mol Imaging. 2020 Jan-Dec;19:1536012120916124. doi: 10.1177/1536012120916124. Mol Imaging. 2020. PMID: 32559121 Free PMC article.

10

A Novel Radioimmune ^99mTc-Labeled Tracer for Imaging Sphingosine 1-Phosphate Receptor 1 in Tumor Xenografts: An In Vitro and In Vivo Study.

Ye M, Gai Y, Ji H, Jiang Y, Qiao P, Wang W, Zhang Y, Xia X, Lan X. Ye M, et al. Among authors: jiang y. Front Immunol. 2021 Aug 18;12:660842. doi: 10.3389/fimmu.2021.660842. eCollection 2021. Front Immunol. 2021. PMID: 34484174 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,025 results

Search Page

Filters